- Home
- NPO vs ZLAB Comparison
NPO vs ZLAB Comparison
Compare NPO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPO
- ZLAB
- Stock Information
- Founded
- NPO 2002
- ZLAB 2013
- Country
- NPO United States
- ZLAB China
- Employees
- NPO N/A
- ZLAB N/A
- Industry
- NPO Metal Fabrications
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- NPO Industrials
- ZLAB Health Care
- Exchange
- NPO Nasdaq
- ZLAB Nasdaq
- Market Cap
- NPO 3.7B
- ZLAB 3.5B
- IPO Year
- NPO N/A
- ZLAB 2017
- Fundamental
- Price
- NPO $174.34
- ZLAB $29.24
- Analyst Decision
- NPO Buy
- ZLAB Buy
- Analyst Count
- NPO 2
- ZLAB 4
- Target Price
- NPO $202.50
- ZLAB $47.37
- AVG Volume (30 Days)
- NPO 150.2K
- ZLAB 1.2M
- Earning Date
- NPO 05-06-2025
- ZLAB 05-08-2025
- Dividend Yield
- NPO 0.71%
- ZLAB N/A
- EPS Growth
- NPO N/A
- ZLAB N/A
- EPS
- NPO 4.01
- ZLAB N/A
- Revenue
- NPO $1,064,400,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- NPO $4.61
- ZLAB $44.43
- Revenue Next Year
- NPO $5.56
- ZLAB $48.68
- P/E Ratio
- NPO $43.49
- ZLAB N/A
- Revenue Growth
- NPO 2.92
- ZLAB 43.72
- 52 Week Low
- NPO $133.50
- ZLAB $15.65
- 52 Week High
- NPO $214.58
- ZLAB $39.77
- Technical
- Relative Strength Index (RSI)
- NPO 62.99
- ZLAB 42.71
- Support Level
- NPO $152.95
- ZLAB $27.61
- Resistance Level
- NPO $181.04
- ZLAB $32.02
- Average True Range (ATR)
- NPO 5.90
- ZLAB 1.23
- MACD
- NPO 4.31
- ZLAB -0.18
- Stochastic Oscillator
- NPO 84.33
- ZLAB 23.41
About NPO Enpro Inc.
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which manufactures and markets sealing products, wheel-end components & systems, and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.